We reported previously that human prostate cancer cell line TSU-Pr1 can dierentiate into microglia-like cells by 12-O-tetra-decanoylphorbol-13-acetate (TPA) treatment. In this study, we identi®ed a signal transduction pathway involved in TPA-induced TSU-Pr1 cell dierentiation and investigated the mechanism of growth arrest that accompanies this dierentiation. TPAinduced dierentiation and growth arrest of TSU-Pr1 cells were inhibited by treatment with Protein kinase C (PKC) inhibitor GF109203X and mitogen-activated protein (MAP) kinase inhibitor PD98059. Treatment of TSU-Pr1 cells with TPA for 15 min or longer resulted in translocation of PKCa, PKCg, and PKCe from cytosolic to membrane fraction. Our results suggest that TPAinduced TSU-Pr1 cell dierentiation is associated with activation of MAP kinase and PKCa, PKCg, and PKCe. The mechanism of growth arrest in TSU-Pr1 cells that underwent TPA-induced dierentiation were examined for factors in the signaling pathway downstream of MAP kinase that control the cell cycle. Upregulation of p21 WAF1/CIP1 cyclin-dependent kinase inhibitor protein was observed in a manner dependent on PKC or MAP kinase. Moreover, adenovirus-mediated overexpression of recombinant p21 WAF1/CIP1 in TSU-Pr1 cells result in growth arrest, morphological change to microglia-like cells, and increased a-naphthyl acetate esterase activity, all of which are associated with cellular dierentiation. Thus, our results indicate that p21 WAF1/CIP1 mediates TPA-induced growth arrest and dierentiation of TSUPr1 cells. Oncogene (2001) 20, 1220 ± 1228.
We reported previously that human prostate cancer cell line TSU-Pr1 can dierentiate into microglia-like cells by 12-O-tetra-decanoylphorbol-13-acetate (TPA) treatment. In this study, we identi®ed a signal transduction pathway involved in TPA-induced TSU-Pr1 cell dierentiation and investigated the mechanism of growth arrest that accompanies this dierentiation. TPAinduced dierentiation and growth arrest of TSU-Pr1 cells were inhibited by treatment with Protein kinase C (PKC) inhibitor GF109203X and mitogen-activated protein (MAP) kinase inhibitor PD98059. Treatment of TSU-Pr1 cells with TPA for 15 min or longer resulted in translocation of PKCa, PKCg, and PKCe from cytosolic to membrane fraction. Our results suggest that TPAinduced TSU-Pr1 cell dierentiation is associated with activation of MAP kinase and PKCa, PKCg, and PKCe. The mechanism of growth arrest in TSU-Pr1 cells that underwent TPA-induced dierentiation were examined for factors in the signaling pathway downstream of MAP kinase that control the cell cycle. Upregulation of p21 WAF1/CIP1 cyclin-dependent kinase inhibitor protein was observed in a manner dependent on PKC or MAP kinase. Moreover, adenovirus-mediated overexpression of recombinant p21 WAF1/CIP1 in TSU-Pr1 cells result in growth arrest, morphological change to microglia-like cells, and increased a-naphthyl acetate esterase activity, all of which are associated with cellular dierentiation. Thus, our results indicate that p21 WAF1/CIP1 mediates
Introduction
Prostate cancer is the most commonly diagnosed neoplasm in men. Despite the bene®cial eects of androgen ablation therapy in patients with prostate carcinoma, advancing prostate cancer usually becomes refractory to hormone therapies (Takahashi et al., 2000) . Dierentiation therapy may be an attractive alternative for patients in which androgen ablation therapy is not eective. We attempted to establish a new prostate cancer therapy by controlling the malignancy of tumor cells through the induction of dierentiation in vitro. We previously showed that treatment of androgen independent human prostate cancer cell line TSU-Pr1 with phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) suppressed proliferation and induced dierentiation into cells displaying characteristics of microglia (Itayasu et al., 1998) . Development of this novel approach to therapeutic intervention of prostate cancer relies on our understanding of the mechanism of TSU-Pr1 cell dierentiation. However, little is known about the mechanism of TPA-induced growth arrest and dierentiation in TSUPr1 cells. TPA activates protein kinase C (PKC), which is a family of serine/threonine-speci®c kinases that appear to be involved in the regulation of cell proliferation, dierentiation, and other cellular functions (Nishizuka, 1995; Dekker and Parker, 1994; Jaken and Kiley, 1994) . The PKC family comprises of 12 members that are subdivided into three groups on the basis of structural and biochemical similarities (Newton, 1997): (1) conventional PKCs (PKCa, PKCbI/II, and PKCg); (2) novel PKCs (PKCd, PKCe, PKCZ, PKCy and PKCm); and (3) atypical PKCs (PKCz, PKCl and PKCi). Conventional PKCs and novel PKCs are activated by TPA. In numerous types of cells, TPA stimulates cellular dierentiation, and this process is mediated by some PKC isozymes. For example, TPA treatment of human myeloid leukemia cell lines is associated with growth arrest, adherence, and increased expression of monocyte surface markers (Rovera et al., 1979 (Rovera et al., , 1982 . Classical PKC inhibitors H-7 and staurosporine block the ability of TPA to induce monocytic dierentiation in these cells (Nishikawa et al., 1986; Barendsen et al., 1990) . PKC activation by TPA is involved in neurite outgrowth in dierentiating human neuroblastoma cells (Heikkila et al., 1993) and in myogenic dierentiation of human rhadomyosarcoma cells (Bouche et al., 1995) .
The mitogen-activated protein (MAP) kinase pathway is believed to play an important role in TPAinduced dierentiation. The MAP kinase pathway is a cascade of phosphorylation reactions involving Raf, MEK1, and the MAP kinases ERK1/2 (Marshall, 1994; Cobb and Goldsmith, 1995) . Treatment of cells with TPA results in activation of Raf (Rapp, 1991) and MAP kinase (Ray and Sturgill, 1987; Hoshi et al., 1988; Rossomando et al., 1989) within minutes. The MAP kinase pathway, which is involved in signal transduction for numerous cellular processes, is essential for growth and dierentiation. Recent evidence suggests that signaling by the MAP kinase pathway not only enhances proliferation by increasing expression of molecules such as cyclin D1 (L'Allemain et al., 1997) but that it also causes growth arrest by increasing expression of molecules such as cyclindependent kinase (CDK) inhibitor protein p21 WAF1/CIP1 (Zezula et al., 1997; Frey et al., 1997) . p21 WAF1/CIP1 inhibits cell cycle progression by interacting with CDK complexes and, in some circumstances, promotes dierentiation. Treatment of several types of cells with TPA induces growth arrest and is accompanied by induction of p21 WAF1/CIP1 (Steinman et al., 1994; Jiang et al., 1994) . Moreover, p21 WAF1/CIP1 induction inhibits growth in various tumor cell lines (Chen et al., 1996; Hall et al., 2000 , Joshi et al., 1998a . Thus, it is likely that p21 WAF1/CIP1 induction plays an essential role in growth arrest that occurs during TPA-induced dierentiation. However, there is little direct evidence demonstrating involvement of p21 WAF1/CIP1 in the numerous phenotypic changes underlying TPA-induced cell dierentiation.
The purpose of this study was to identify signal transduction pathways that mediate growth arrest and dierentiation and to examine the role of p21 WAF1/CIP1 induction in TSU-Pr1 cells treated with TPA.
Results

Treatment of TSU-Pr1 cells with PKC or MEK inhibitors blocks TPA-induced growth arrest and differentiation
To explore the mechanisms of TPA-induced dierentiation in TSU-Pr1 cells, the eects of several PKC and MAP kinase inhibitors on growth arrest and dierentiation were examined. The inhibitor concentration was suciently low such that neither cell proliferation nor viability was aected. Treatment of exponentially growing TSU-Pr1 cells with 10 78 M TPA rapidly inhibited growth. However, co-treatment of these cells with TPA and the potent, selective PKC inhibitor GF109203X, which is a competitive inhibitor with respect to ATP binding to PKC, or the selective MEK inhibitor PD98059, which is a noncompetitive inhibitor with respect to ATP binding to MEK, almost completely suppressed growth arrest (Figure 1 ). The PI3 kinase inhibitor wortmannin, the p38/RK inhibitor SB203580, the tyrosine kinase inhibitor genistein, and the protein kinase A (PKA) inhibitor KT-5720 had no eect on TPA-induced growth arrest of TSU-Pr1 cells (data not shown).
Morphologic changes were examined to evaluate cell dierentiation. As reported previously, TPA-treated TSU-Pr1 cells displayed microglia-like morphologic changes, including appearance of ameboid projections and a rami®ed cell shape (Itayasu et al., 1998) . Treatment of TSU-Pr1 cells with TPA for 7 days induced morphologic changes in 75% of the treated cells (Figure 2a) . a-naphthyl acetate esterase activity was also examined to evaluate the expression of microglial characteristics. In TPA-treated TSU-Pr1 cells, a-naphthyl acetate esterase activity increased substantially and correlated with cellular dierentiation from days 3 to 7 (Figure 2b ). Co-treatment of TSU-Pr1 cells with TPA and the PKC inhibitor GF109203X or the MEK inhibitor PD98059 suppressed TPA-induced a-naphthyl acetate esterase activity and morphological change (Figure 2a,b) . Moreover, MEK/ERK inhibitor U0126 also suppressed TPA-induced dierentiation of TSU-Pr1 cells (data not shown). Our data suggest that endogenous PKC and MAP kinases mediate TPAinduced dierentiation of TSU-Pr1 cells.
Translocation of PKC isozymes from cytosol to membranes in TSU-Pr1 cells by treatment with TPA
Since we detected that PKC is associated with the dierentiation of TSU-Pr1 cells, we next attempted to determine which PKC isoform is activated by TPA and participates in dierentiation of TSU-Pr1 cells. We ®rst examined about alteration of expression of PKC isozymes in TSU-Pr1 cells treated with TPA by Western blot analysis. Expression of eight PKC isozymes (a, g, d, e, y, m, l, and i) were detected in undierentiated TSU-Pr1 cells (Figure 3 ). However, no increases in PKC protein levels were detected during TSU-Pr1 cell dierentiation. Thus change in PKC activity as a consequence of change in PKC protein expression is not likely to occur in TPA-treated TSUPr1 cells.
PKC isozymes become activated upon translocation from cytosol to membranes. To investigate possible activation of PKC isozymes by translocation, changes in subcellular distribution of PKC isozymes were examined in TSU-Pr1 cells treated with TPA. The quantity of PKCa, PKCg, and PKCe protein decreased in the cytosolic fraction and increased in the membrane fraction of TSU-Pr1 cells in less than 15 min after TPA treatment ( Figure 4 ). During this treatment period, the total quantity of each PKC isoform did not change (data not shown). These results indicate that PKCa, PKCg, and PKCe protein translocated from cytosol to membranes of TSU-Pr1 cells treated with TPA. Thus, TPA treatment is likely to activate PKCs, especially PKCa, PKCg, and PKCe, and to participate in the dierentiation process in TSU-Pr1 cells.
p21 WAF1/CIP1 induction during TPA-mediated differentiation
To explore how treatment with TPA impedes proliferation of TSU-Pr1 cells, several cell cycle factors, such as cyclin, CDK, and CDK inhibitor, were examined. p21 WAF1/CIP1 induction was observed early in the treatment time course (Figure 5a ,b). After TPA treatment, marked increases were observed in p21 WAF1/CIP1 mRNA ( Figure 5a ) after 30 min and in WAF1/CIP1 protein ( Figure 5b ) after 1 h. Upregulation of p21 WAF1/CIP1 protein continued for 6 h after TPA treatment and did not return to the basal level for at least 7 days (data not shown).
Upon terminal dierentiation, p21 WAF1/CIP1 may play an important role in growth arrest by suppressing CDK activity and, consequently, inhibiting retinoblastoma protein (pRB) phosphorylation. Thus, the phosphorylation state of pRB was examined in TPAtreated TSU-Pr1 cells by Western blot analysis. Most of the lower mobility, hyperphosphorylated pRB disappeared 24 h after TPA treatment (Figure 5c ). This suggests that treatment of TSU-Pr1 cells with TPA result in activation of pRB by dephosphorylation.
Since induction of p21 WAF1/CIP1 by TPA is likely to be mediated by PKC or MAP kinases, the eects of various inhibitors of these kinases on TPA-induced expression of p21 WAF1/CIP1 were examined. Pretreatment of TSU-Pr1 cells with the PKC inhibitor GF109203X, the MEK inhibitor PD98059, or the MEK/ERK inhibitor U0126 almost completely suppressed the rapid induction of p21 WAF1/CIP1 protein by TPA ( Figure  5d ). This result indicates that p21 WAF1/CIP1 induction in TSU-Pr1 cells by TPA involves PKC and MAP kinase activation. As described above, these inhibitors suppressed TPA-induced dierentiation of TSU-Pr1 cells. Staurosporine, a potent inhibitor that aects a broad spectrum kinase including PKC, failed to inhibit cellular dierentiation and p21 WAF1/CIP1 expression (data not shown) in TPA-treated TSU-Pr1 cells. Moreover, the p38/RK inhibitor SB203580, the PI3 kinase inhibitor wortmannin, and the PKA inhibitor KT-5720 neither suppressed TPA-induced growth arrest nor inhibited TPA-induced p21 WAF1/CIP1 expression (data not shown). These results suggest that p21 WAF1/CIP1 induction is associated with TPA-induced dierentiation of TSU-Pr1 cells.
p21
WAF1/CIP1 overexpression induces growth arrest, morphologic change, and a-naphthyl acetate esterase activity in TSU-Pr1 cells
To investigate the role of p21 WAF1/CIP1 induction in TPAinduced dierentiation of TSU-Pr1 cells, the eect of p21 WAF1/CIP1 overexpression in TSU-Pr1 cells using recombinant adenovirus encoding p21 WAF1/CIP1 (Advp21) was examined. Infection of TSU-Pr1 cells with Adv-p21 at a multiplicity of infection (MOI) ranging between 3 and 1000 gradually increased expression of p21 WAF1/CIP1 protein (Figure 6a ). The level of p21
protein found in cells infected with Adv-p21 at a MOI of 100 was similar to that of uninfected cells treated with 10 78 M TPA. Infection of TSU-Pr1 cells with Adv-p21 at a MOI ranging between 10 and 1000 reduced the viable cell number (Figure 6b ). Apoptosis and other causes of cell death were not observed in infected TSU-Pr1 cells. These results suggest that overexpression of p21 WAF1/CIP1 leads to growth arrest in TSU-Pr1 cells.
Cell cycle alterations were subsequently compared in TPA-treated cells and Adv-p21-infected cells (Figure 7 ). Both TPA treatment and Adv-p21 infection decreased the percentage of S phase cells, increased the percentage of G2/M phase cells, and had no eect on the percentage of G1 cells. These results suggest that p21 WAF1/CIP1 blocks the cell cycle at both G1 and G2. Morphologic changes and a-naphthyl acetate esterase activity were examined in Adv-p21-infected cells to de®ne the role of p21 WAF1/CIP1 in induction of dierentiation. Interestingly, changes in morphology and anaphthyl acetate esterase activity were similar in both TSU-Pr1 cells infected with Adv-p21 and cells treated for 3 days with TPA. Morphological changes were evident in 30% of TSU-Pr1 cells infected with Adv-p21 at a MOI of 100 and in 35% of cells treated with TPA at 10 78 M (Figure 8a ). a-naphthyl acetate esterase activation was induced in about 11% of TSU-Pr1 cells infected with Adv-p21 at a MOI of 100 and in 14% of cells treated with TPA at 10 78 M (Figure 8b ). These results suggest that induction of p21 WAF1/CIP1 causes growth arrest and stimulates dierentiation, which includes changes in cell morphology and induction of a-naphthyl acetate esterase activity, in TSU-Pr1 cells treated with TPA.
Discussion
TPA is a well known, potent inducer of dierentiation in cells such as myeloid leukemia cells and neuroblastoma (Rovera et al., 1979 (Rovera et al., , 1982 Bouche et al., 1995; Heikkila et al., 1989; Yamauchi et al., 1989) . We previously showed that the androgen-independent human prostate cancer cell line TSU-Pr1 dierentiates into microglia-like cells upon treatment with TPA (Itayasu et al., 1998) . In the present study, we examined the involvement of the PKC and MAP kinase pathways as well as the role of p21 WAF1/CIP1 in TSU-Pr1 cell dierentiation. Our results suggest that TPA-induced dierentiation of TSU-Pr1 cells is associated with p21 WAF1/CIP1 induction via the PKC and the MAP kinase pathways. We showed that overexpression of p21 WAF1/CIP1 induces growth arrest, morphologic change, and a-naphthyl acetate esterase activity in TSU-Pr1 cells. p21
is known to directly inhibit kinase activities of a wide range of cyclin-CDK complexes, resulting in a general arrest of the cell cycle. The introduction of p21 WAF1/CIP1 expression constructs results in inhibition of the growth in various tumor cell lines (Chen et al., 1996; Hall et al., 2000, Joshi et Exit from the cell cycle is a prerequisite for terminal dierentiation, and p21 WAF1/CIP1 expression is induced during terminal dierentiation both in vitro (Steinman et al., 1994; Halevy et al., 1995; Missero et al., 1995) and in vivo (Huppi et al., 1994; Macleod et al., 1995; Gartel et al., 1996) . Expression of antisense p21 WAF1/CIP1 transgene in leukemia cell lines suppressed p21 WAF1/ CIP1 expression and inhibited phorbol ester-or vitamin D3-induced dierentiation (Asada et al., 1998; Wang et al., 1998) . These results suggest that p21 WAF1/CIP1 induction plays an important role in dierentiation. Many studies show correlative links; fewer show causal association between p21 WAF1/CIP1 induction and dierentiation. In PC12 cells, overexpression of p21 WAF1/CIP1 alone had little eect on phenotype dierentiation, but it substantially accelerated nerve growth factor-induced dierentiation (Erhardt and Pittman, 1998) . In a study of monoblastic cell lines (Liu et al., 1996) , dierentiation was induced by ectopic overexpression of p21 WAF1/CIP1 alone, and its overexpression was greatly facilitated eector-induced dierentiation. However, dierentiation was signi®-cantly greater in monoblastic cells treated with eector alone than in cell overexpressing p21 WAF1/CIP1 . Our data showed that ectopic p21 WAF1/CIP1 expressed at levels comparable to that of TPA-induced, endogenous p21 WAF1/CIP1 stimulated morphological change and anaphthyl acetate esterase activity to the same degree as dose TPA treatment alone in TSU-Pr1 cells. This suggests that p21 WAF1/CIP1 is sucient for induction of morphological change and a-naphthyl acetate esterase activity.
In several dierent cell types, morphologic change appears to be closely associated with p21 WAF1/CIP1 induction. For example, cancer cells displayed enlarged nuclei and a¯attened cellular shape upon transient overexpression of a p21 WAF1/CIP1 transgene (Kagawa et al., 1999) , and expression of p21 WAF1/CIP1 altered morphology of malignant cells (Yang et al., 1995) .
We are ®rst to report that p21 WAF1/CIP1 induction leads to an increase in a-naphthyl acetate esterase activity. Several other proteins interact with p21 WAF1/CIP1 (Mitsui et al., 1999; McShea et al., 2000) . Moreover, p21 WAF1/CIP1 expression leads to alterations in expression of many other genes (Chang et al., 2000) . We speculate, on the basis of these ®ndings, that p21 WAF1/CIP1 protein is involved in a variety of cellular functions. Here, we propose that stimulation of anaphthyl acetate esterase activity is a novel cellular action of p21 , and its induction is mediated by PKC and MAP kinase pathways, and this mechanism of p21 WAF1/CIP1 induction is supported by earlier studies. For example, PKC inhibitor staurosporine inhibited TPA-induced p21 WAF1/CIP1 protein expression (Zeng and El-Deiry, 1996) , and PMA-induced p21 WAF1/CIP1 upregulation is involved in integrating PKC or MAP kinase pathways (Barboule et al., 1999; Das et al., 2000) . TPA is a wellcharacterized activator of PKC. Several studies suggest that PKC isoforms directly regulate Raf-1 activity (Kolch et al., 1993) . Moreover, PKC activates the MEK-ERK pathway in a Raf-dependent manner (Ueda et al., 1996) . The Raf-1/MEK/ERK pathway also regulates expression of the p21 WAF1/CIP1 gene (Beier et al., 1999) . We speculate that TPA activates certain PKC isozymes, which subsequently activate the MAP kinase pathway and upregulate p21 WAF1/CIP1 expression in TSU-Pr1 cells. Here, we found that TPA activates PKCa, PKCg, and PKCe in TSU-Pr1 cells. Since Raf-1 is directly phosphorylated and activated by PKCa (Kolch et al., 1993) , its activation is likely associated with induction of p21 WAF1/CIP1 expression and, consequently, TSU-Pr1 cell dierentiation. To understand the role of each dierent PKC isozyme in TPA-induced TSU-Pr1 cell dierentiation, it may be necessary to examine the eect of increasing or decreasing cellular expression of each PKC subtype.
Little is known about the mechanism by which p21 WAF1/CIP1 gene expression is induced in TSU-Pr1 cells treated with TPA. The 52-kD activator protein (AP2), which is a transcription factor implicated in signaling terminal dierentiation, activates p21 WAF1/CIP1 expression after treatment of cells with TPA (Zeng et al., 1997) . Beier et al. (1999) suggested that p21 WAF1/CIP1 induction via the Raf-1/MEK/ERK pathway is associated with Ets2. Furthermore, activation of both AP2 and Ets2 transcription factors are mediated by the MAP kinase pathway (Milanini et al., 1998; Fowles et al., 1998) . Thus, TPA-induced p21 WAF1/CIP1 expression in TSU-Pr1 cells may be mediated by these transcription factors. Akashi et al. (1999) showed that the phorbol ester PMA markedly stabilized p21 mRNA is enhanced by a MAP kinase-dependent mechanism (Liu et al., 2000) . In a preliminary study, we found that treatment of TSU-Pr1 cells with TPA slightly increased p21 WAF1/CIP1 mRNA stability. It is likely that TPA induces p21 WAF1/CIP1 expression in TSU-Pr1 cells by both transcriptional and post-transcriptional mechanisms.
In this study, we showed that treatment of androgenindependent human prostate cancer TSU-Pr1 cells with TPA induced p21 WAF1/CIP1 expression, which mediates growth arrest and cellular dierentiation. These results underscore the utility of p21 WAF1/CIP1 as a potentially important target for dierentiation therapy in androgen-independent prostate cancers. Further investigation of the mechanism of TPA-induced p21 WAF1/CIP1 induction will be critically important for identifying more signaling molecules that may serve as additional targets for novel therapeutic agents. We believe that dierentiation therapy is likely to improve clinical prognosis of androgen-independent prostate cancer.
Materials and methods
Cell culture
Human prostate cancer TSU-Pr1 cells were kindly provided by Dr Tatsuo Izumi. This cell line was established from a metastatic lymph node biopsy (Iizumi, et al., 1987) . Cells were maintained in RPMI 1640 medium (GIBCO, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Filtron, Victoria, Australia) and grown at 378C in a humidi®ed atmosphere consisting of 5% CO 2 and 95% air. Treated cells were stained by a-naphthyl acetate esterase assay kit (Sigma Chemical Co., St. Louis, MO, USA) to evaluate microglial characteristics, as previously described (Yam et al., 1971) .
Measurement of viable cell number
Western blot analysis
To prepare lysates, 10 6 cells were suspended in lysis buer (10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM PMSF, 20 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mM b-glycerophospate, 0.1 mM NaVO 4 , 1 mM NaF) and subjected to three cycles of freezing and thawing. Whole cell extracts were centrifuged at 17 000 g for 10 min to remove insoluble cell debris. Puri®ed cytosol and membrane lysates were prepared as previously described (Powell et al., 1996) . Protein concentration was determined with the BIO-RAD protein assay (Bio-Rad, Hercules, CA, USA). Denatured cell extracts were analysed by SDS-polyacrylamide gel electrophoresis, and proteins were transferred to PVDF membranes. Blots were blocked overnight at 48C in 5% nonfat milk and 1% Triton X-100 in phosphate-buered saline and then incubated for 2 h at room temperature with PKC antibodies (Transduction Laboratories, Lexington, KY, USA) or p21 antibodies (PharMingen, San Diego, CA, USA). The blots were then washed three times and incubated for 1 h with HRP-conjugated secondary antibodies. Proteins were visualized with enhanced chemiluminescence (ECL) detection system (Amersham-Pharmacia Biotech, Buckinghamshire, UK).
Northern blot analyses
Total cellular RNA was isolated with ISOGEN (Wako, Osaka, Japan). Quality and quantity of total RNA were determined by measuring the absorbance at 260 nm. Poly(A) + RNA was puri®ed with Oligotex-dT30 (TAKARA, Shiga, Japan). Three mg of each poly(A) + RNA sample was electrophoresed on 1.2% agarose-15% formaldehyde gels and transferred to Hybond-N membranes (Amersham-Pharmacia Biotech). Hybridizations were carried out according to the manufacturer's instructions. Complementary DNA probe was labeled with 32 P dCTP and random-primer DNA labeling kit (TAKARA). DNA probes were ampli®ed by RT ± PCR with the following primers: 5'-CCCAAGCTTCCTTGTG-GAGCCGGAGCTGG-3' (p21-sense) and 5'-GCTCTAGAC-TAAGGCAGAAGATGTAGA-3' (p21-antisense).
Generation of recombinant adenovirus and infection
The fragment containing 5-590 (nt) of human p21 WAF1/CIP1 sequence (El-Deiry et al., 1993) cloned into pBluescript II SK (+) (pSKII+hp21). The XhoI/BglI fragment of human p21 cDNA from pSKII+hp21 was inserted into the XhoI/BamHI site of pCAcc, which generated pCA-hp21. The cosmid pAxCA-hp21 was generated by ligating the blunt-ended SalI/ HindIII expression cassette from pCA-hp21 to the SwaI site of the cosmid pAxcw. The cosmid was cotransfected with the genomic DNA-terminal protein complex of adenovirus type 5 (Ad5dlX), and the recombinant adenoviruses were generated according to the method described by Miyake et al. (1996) . Cells were infected at speci®ed multiplicities based on titers determined by plaque assay of human 293 cells. TSU-Pr1 cells were seeded at a density of 10 5 cells per 100-mm dish and incubated for 24 h. On the next day, the medium was replaced with 1 ml of virus serially diluted in fresh medium. After incubation for 1 h at 378C, each cell culture was supplemented with growth medium and incubated for 72 h at 378C.
Flow cytometry
Cells were plated at a density of 5610 4 cells per 100-mm dish and treated with TPA or infected with serial dilution of adenovirus 12 h later. Seventy-two hours after infection, cells were trypsinized, collected in PBS, and ®xed in 70% cold ethanol. After RNase treatment, cells were stained with 50 mg/ml propidium iodide in PBS. Flow cytometry was performed on a Becton Dickinson FACScan, and data were analysed by ModFit software (Verity Software House, Inc., Topsham, ME, USA). The percentages of nuclei in G 0 -G 1 , S, and G 2 -M phases of the cell cycle were determined from 10 000 gated cells.
Abbreviations TPA, 12-O-tetra-decanoylphorbol-13-acetate; PKC, protein kinase C; PKA, protein kinase A; MAP kinase, mitogenactivated protein kinase; ERK, extracellular signal-regulated protein kinase; FBS, fetal bovine serum; JNK, c-Jun NH 2 -terminal protein kinase; CDK, cyclin dependent kinase; AP2, activator protein 2; pRB, retinoblastoma protein.
